Queensland, Australia

Pamela Pollock

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 1.5

ph-index = 2

Forward Citations = 16(Granted Patents)


Company Filing History:


Years Active: 2015-2019

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations in Cancer Diagnosis and Treatment by Pamela Pollock

Introduction

Pamela Pollock is a distinguished inventor based in Queensland, Australia. She has made significant contributions to the field of cancer research, particularly in the diagnosis and treatment of endometrial cancer. With a total of three patents to her name, her work focuses on innovative methods that enhance the understanding and management of this disease.

Latest Patents

Pamela Pollock's latest patents include groundbreaking methods for diagnosing, classifying, and treating endometrial cancer. One of her notable inventions describes diagnostic and therapeutic applications based on specific activation mutations in the FGFR2 gene and its expression products. This invention encompasses nucleotide sequences, amino acid sequences, probes, and primers related to FGFR2 activation mutants, along with kits designed for diagnosing and classifying endometrial cancer in patients. Another significant patent addresses the susceptibility of tumors to tyrosine kinase inhibitors and their treatment. This disclosure provides variants of tyrosine kinase proteins and nucleic acids, particularly FGFR2 variants, which are associated with drug resistance. It also outlines methods for diagnosis and theranosis, utilizing these molecules and fragments, along with kits for implementing these methods and compositions.

Career Highlights

Throughout her career, Pamela Pollock has worked with esteemed organizations such as the Translational Genomics Research Institute and Queensland University of Technology. Her research has been pivotal in advancing the understanding of endometrial cancer and developing effective treatment strategies.

Collaborations

Pamela has collaborated with notable colleagues, including Sara Byron and Paul Goodfellow, contributing to a rich exchange of ideas and expertise in her field.

Conclusion

Pamela Pollock's innovative work in cancer diagnosis and treatment exemplifies the impact of research and invention in improving patient outcomes. Her contributions continue to shape the future of oncology and provide hope for better diagnostic and therapeutic options for endometrial cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…